1. Home
  2. APRE vs CLRO Comparison

APRE vs CLRO Comparison

Compare APRE & CLRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • CLRO
  • Stock Information
  • Founded
  • APRE 2006
  • CLRO 1983
  • Country
  • APRE United States
  • CLRO United States
  • Employees
  • APRE N/A
  • CLRO N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • CLRO Radio And Television Broadcasting And Communications Equipment
  • Sector
  • APRE Health Care
  • CLRO Technology
  • Exchange
  • APRE Nasdaq
  • CLRO Nasdaq
  • Market Cap
  • APRE 8.3M
  • CLRO 9.3M
  • IPO Year
  • APRE 2019
  • CLRO N/A
  • Fundamental
  • Price
  • APRE $1.47
  • CLRO $5.77
  • Analyst Decision
  • APRE Strong Buy
  • CLRO
  • Analyst Count
  • APRE 1
  • CLRO 0
  • Target Price
  • APRE $20.00
  • CLRO N/A
  • AVG Volume (30 Days)
  • APRE 40.4K
  • CLRO 53.0K
  • Earning Date
  • APRE 11-06-2025
  • CLRO 11-14-2025
  • Dividend Yield
  • APRE N/A
  • CLRO N/A
  • EPS Growth
  • APRE N/A
  • CLRO N/A
  • EPS
  • APRE N/A
  • CLRO N/A
  • Revenue
  • APRE $841,012.00
  • CLRO $9,689,000.00
  • Revenue This Year
  • APRE N/A
  • CLRO N/A
  • Revenue Next Year
  • APRE N/A
  • CLRO N/A
  • P/E Ratio
  • APRE N/A
  • CLRO N/A
  • Revenue Growth
  • APRE N/A
  • CLRO N/A
  • 52 Week Low
  • APRE $1.37
  • CLRO $3.83
  • 52 Week High
  • APRE $5.01
  • CLRO $21.00
  • Technical
  • Relative Strength Index (RSI)
  • APRE 45.12
  • CLRO 61.93
  • Support Level
  • APRE $1.46
  • CLRO $5.53
  • Resistance Level
  • APRE $1.57
  • CLRO $6.14
  • Average True Range (ATR)
  • APRE 0.08
  • CLRO 0.46
  • MACD
  • APRE 0.01
  • CLRO 0.06
  • Stochastic Oscillator
  • APRE 54.45
  • CLRO 44.17

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About CLRO ClearOne Inc. (DE)

ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.

Share on Social Networks: